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Summary
  Introduction:  The high frequency of cases of circulatory system conditions in Europe and other countries aro-
und the world requires scientific research to define risk factors of early atherosclerotic changes. 
The aim of the present study was to define which students are at danger of developing atherosc-
lerosis by means of measuring cholesterol and triglyceride levels in blood as well as defining the 
correlation between atherosclerosis risk factors and arterial blood pressure, physical fitness and 
efficiency of the subjects.
  Material/Methods:  The research covered 167 students of Public Junior High School ¹1 in Biala Podlaska aged 13–15 
years. Accutrend GCT was employed to define the levels of total cholesterol and triglycerides in 
the screen test. Those students who were found to have increased values of biochemical parame-
ters of capillary blood were subjected to additional blood tests aiming to define complete lipid 
profile of venous blood. The blood pressure in subjects was tested three times. The Moderate-to-
Vigorous Physical Activity (MVPA) test, suggested by American authors, was employed to de-
fine physical activity in subjects. EUROFIT was employed to define physical efficiency.
  Results:  Among the 167 subjects there were found 42 students (25.1%) whose lipid level in capillary blo-
od proved to be increased. Full lipid profile tests proved that 16 students (9.6%) had increased 
blood lipid levels; those subjects constituted the risk group. Subjects in the risk group were cha-
racterized by lower levels of physical activity and physical efficiency compared to subjects with 
normal blood lipid level. Moreover, the frequency of hypertension was greater in risk group sub-
jects compared to subjects with normal blood lipid levels.
  Inferences:  Students diagnosed with atherosclerosis risk factors require observation and early prophylactics 
by adopting habits of healthy physical activity.
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       -               -               -               -               -       IntroductIon
Cardiovascular disorders are the most common cause of 
deaths in humans in numerous developed and developing 
countries around the globe. They cause over 4 million de-
aths in Europe annually (55% of deaths in females and 
43% of deaths in males). In Poland cardiovascular disor-
ders are responsible for 50% of all deaths, among which 
ischemic heart disease (IHD) is the most common [5,11].
Atherosclerosis is responsible for the basis of clinical symp-
toms of IHD, and is a chronic, inflammatory degenerati-
ve condition of complex etiopathogenesis. The atherosc-
lerotic process is a continuous one and lasts many years, 
being characterized by focused accumulation of choleste-
rol, smooth muscle cells and fibrous tissue in tunica media 
of artery walls. As a result of those changes there develop 
atherosclerotic plaques which cause occlusion of the arte-
ry and obstruct blood flow. Advanced atherogenesis often 
leads to death through such hard endpoints as heart attack, 
stroke, cardiac dysrhythmia and heart failure [3,5,11,18,21].
The process of atherosclerosis starts with reversible chan-
ges called fatty streaks. The first fatty streaks can appear 
in childhood [30,52,53,54]. However, clinical symptoms 
of atherosclerosis, caused by development of atheroscle-
rotic plaques in arterial blood vessels, are usually prono-
unced only in the fourth decade of life. Therefore, early 
identification of risk factors of atherosclerosis in children 
and youth is considered to be of immense importance to 
prevent cardiovascular diseases in adults [3].
There are several risk factors for developing atherosclero-
sis which are related to both biological body features and 
Streszczenie
  Wstęp:  Bardzo częste występowanie chorób układu krążenia w Europie i innych krajach na świecie uza-
sadnia podejmowanie badań profilaktycznych dotyczących identyfikacji czynników ryzyka roz-
woju wczesnych zmian miażdżycowych. Celem pracy była próba rozpoznania grupy uczniów 
obciążonych ryzykiem rozwoju miażdżycy na podstawie oznaczenia stężeń cholesterolu i trigli-
cerydów we krwi oraz poszukiwanie związków między stwierdzonymi czynnikami ryzyka a ci-
śnieniem tętniczym, wydolnością i aktywnością fizyczną badanych.
 Materiał/Metody:  Badaniami objęto 167 uczniów obu płci w wieku 13–15 lat uczęszczających do Publicznego 
Gimnazjum nr 1 w Białej Podlaskiej. Oznaczenia cholesterolu całkowitego i triglicerydów me-
todą przesiewową dokonano za pomocą aparatu Accutrend GCT. Osoby, u których stwierdzono 
podwyższony poziom parametrów biochemicznych we krwi kapilarnej zostały poddane dodat-
kowym badaniom krwi, polegającym na pełnym oznaczeniu lipidogramu we krwi żylnej. Wśród 
badanych dokonano 3-krotnego pomiaru ciśnienia tętniczego. Aktywność fizyczna badanych była 
oceniana na podstawie amerykańskiego testu MVPA (Moderate-to-Vigorous Physical Activity). 
Do oceny wydolności fizycznej badanych uczniów zastosowano jedną z prób Europejskiego Testu 
Sprawności fizycznej – EUROFIT.
  Wyniki:  W badaniach przesiewowych spośród 167 badanych uczniów wyłoniono 42 osoby (25,1%) z pod-
wyższonymi wskaźnikami lipidowymi we krwi kapilarnej. Po oznaczeniu pełnego lipidogra-
mu we krwi żylnej tych osób, potwierdzono podwyższone wskaźniki lipidowe u 16 osób (9,6%) 
[grupa ryzyka]. Młodzież stanowiąca grupę ryzyka charakteryzowała się mniejszą aktywnością 
i wydolnością fizyczną od osób z prawidłowymi wartościami wskaźników lipidowych. Ponadto 
częstość występowania nadciśnienia tętniczego wśród uczniów należących do grupy ryzyka była 
większa niż w grupie z prawidłowymi wartościami wskaźników lipidowych.
  Wnioski:  Uczniowie, u których stwierdzono obecność czynników ryzyka miażdżycy wymagają obserwa-
cji i wczesnej profilaktyki przez wyrabianie nawyków aktywnego wypoczynku.
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       -               -               -               -               -       life style features, but the following are the most common: 
lipid metabolism disorders, hypertension (often resulting 
from unhealthy diet) and low physical activity which lead 
to obesity [6,16,33,37,44,56].
Numerous clinical and epidemiological studies prove the 
positive influence of regular physical activity on reducing 
both risk factors of atherosclerosis and mortality caused 
by cardiovascular disorders [4,12,15,17,27,28,32,46]. The 
protective role of regular physical activity is closely con-
nected with anti-atherosclerotic effects resulting from im-
proved lipid profile, reduced level of total cholesterol (TC), 
low-density lipoprotein (LDL) cholesterol (LDL-C) and tri-
glycerides (TG) as well as increase of high-density lipopro-
tein (HDL) cholesterol (HDL-C) [20,23,24,32,36,48,50]. 
Moreover, regular physical activity is usually correlated with 
lower values of arterial blood pressure. It has been shown 
not only in adults but in children and youth as well [2,38].
Dietary interventions, which lead to improvement of blo-
od lipid profile, reduction of body mass and arterial blood 
pressure, could significantly slow down, stop and even re-
vert early atherosclerotic changes in arteries [14,26,29,40].
Increased levels of cholesterol and triglycerides are unqu-
estionably factors which induce development of atherosc-
lerotic (atheromatous) plaque, which is why defining tho-
se levels in youth has become very common.
The aim of the present paper was to define which students 
of Public Junior High School №1 in Biala Podlaska are at 
danger of developing atherosclerosis by means of measu-
ring cholesterol and triglyceride levels in blood, as well 
as to define the relation between atherosclerosis risk fac-
tors and arterial blood pressure, physical fitness and effi-
ciency of the subjects.
MaterIal and Methods
The research covered 167 students (85 females and 82 
males) of Public Junior High School ¹1 in Biala Podlaska 
aged 13–15 years.
The research was conducted following the approval from 
the parents of subjects and the school’s authorities. The 
aim of the screening was to define which subjects had in-
creased blood levels of cholesterol and triglycerides which 
could signify danger or development of atherosclerosis.
Accutrend GCT by the Swiss manufacture ROCHE was 
employed to screen the subjects in order to define total 
cholesterol and triglyceride levels. The above mentioned 
biochemical parameters were measured in capillary blood 
of subjects (fasting conditions); blood samples were taken 
from finger tips. Values of total cholesterol <200 mg/dl and 
triglycerides <180 g/dl were considered normal.
Those students who were found to have increased values of 
biochemical parameters of capillary blood were subjected 
to additional blood tests aiming to define complete lipid 
profile of venous blood (TC, LDL-C, HDL-C, TG). Values 
of biochemical parameters in the subjects were compared 
with the laboratory norms [11,24].
Subjects who were found to have such poor health indica-
tors as increased values of TC, LDL and TG as well as re-
duced values of HDL were classified in the risk group of 
atherosclerosis. Students from the risk group of athero-
sclerosis as well as students whose biochemical parame-
ters were normal were subjected to further tests aiming to 
find such further atherosclerosis risk factors as increased 
blood pressure, low levels of physical activity and physi-
cal efficiency.
According to the fourth report from the National High Blood 
Pressure Education Program the blood pressure in subjects 
was tested three times [55]. Correct interpretation of blo-
od pressure centiles for gender, age and body height (con-
sidering individual physical development of subjects) was 
used to define arterial hypertension in the subjects tested.
Physical activity of subjects was defined by means of 
a physical activity test suggested by American authors 
J. Prochaska, J. Sallisa and B. Long. The test estimated 
Moderate-to-Vigorous Physical Activity (MVPA) based 
on a 7-point system [42].
Physical efficiency was defined by means of EUROFIT 20 
m endurance shuttle-run test. The subjects were asked to 
increase their running speed after each 20 m section cove-
red. Additionally, maximal oxygen consumption VO2max 
(ml/kg/min) was defined based on the number of 20 m 
sections covered.
results
Among the 167 subjects aged 13–15 years there were fo-
und 42 students (25.1%) whose lipid level in capillary 
blood proved to be increased (Table 1), including 16 stu-
dents (9.6%) whose cholesterol level proved to be incre-
ased and 26 students (15.6%) whose triglyceride level pro-
ved to be increased.
Students whose lipid level in capillary blood proved to be 
increased were subjected to further tests (Table 2). After 
defining complete lipid profile of capillary blood (TC, 
LDL-C, HDL-C, TG) 16 students (9.6%) were found to 
have increased lipid values (atherosclerosis risk group). 
The atherosclerosis risk group contained 7 males (4.2%) 
and 9 females (5.4%). Five subjects (3%), 2 males (1.2%) 
and 3 females (1.8%) were characterized by increased va-
lues of total cholesterol (above 200 mg/dl). Average total 
cholesterol value in those five subjects was 242±25.4 mg/
dl, whereas higher total cholesterol values were found in 
males (248.0±39.6 mg/dl) compared to females (239.0±21.5 
mg/dl). Two subjects were found to have their LDL le-
vel increased (above 155 mg/dl), whereas the average va-
lue was 160.6±2.6 mg/dl. Only one subject was found to 
have an insufficient level of HDL with the result of 33.1 
mg/dl. Eleven subjects (6.6%), 5 males (3.0%) and 6 fe-
males (3.6%) were found to have increased values of tri-
glycerides (above 180 mg/dl). Average triglycerides value 
in the risk group was 256±58.9 mg/dl, whereas higher va-
lues were found in females (276.0±55.3 mg/dl) compared 
to males (232.2±59.7).
The data presented in tables 3 and 4 prove that subjects in 
the atherosclerosis risk group were characterized by lower 
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       -               -               -               -               -       level of physical activity and physical efficiency when com-
pared to subjects whose lipid values proved to be normal. 
Physical activity measured by means of MVPA was 3.6±0.9 
points in the risk group and 4.0±1.1 points in subjects who-
se lipid values proved to be normal (Table 3). Physical ef-
ficiency measured by means of maximal oxygen consump-
tion (VO2max) was found to be 29.3±3.6 ml/kg/min in the 
risk group and 30.0±4.3 in subjects whose lipid values 
proved to be normal.
Hypertension (HTN) was frequently found in the risk gro-
up subjects compared to subjects whose lipid values pro-
ved to be normal (Table 5). However, prehypertension 
was more frequently found in subjects who did not be-
long to the group of risk. Also average values of hyper-
tension (both systolic and diastolic) were more frequently 
found in risk group subjects compared to the rest of the 
subjects. Average systolic hypertension was 135.1±17.1 
mmHg in risk group subjects and 127.0±12.6 mmHg in 
Specification
Subjects
Males and females Males Females
N % n % n %
167 100.0 82 49.1 85 50.9
Cholesterol>200 mg/dl 16 9.6 8 4.8 8 4.8
Triglycerides>180 mg/dl 26 15.6 9 5.4 17 10.2
Subjects with increased values of 
biochemical parameters in capillary blood  42 25.1 17 10.1 25 15.0
Table 1. Number and percentage (%) of subjects aged 13–15 years with increased values of biochemical parameters in capillary blood
Specification
Subjects
Males and females Males Females
n % n % n %
167# 100.0 82 49.1 85 50.9
Cholesterol>200 mg/dl 5 3.0 2 1.2 3 1.8
Total cholesterol (mg/dl)
mean ± SD 242.6±25.4 248.0±39.6 239.0±21.5
HDL<40 mg/dl 1 0.6 – – 1 1.2
HDL (mg/dl)  33.1 – 33.1
LDL>155 mg/dl 2 1.2 1 1.2 1 1.2
LDL (mg/dl)
mean ± SD 160.6±2.6 158.7 162.6
Triglycerides>180 mg/dl 11 6.6 5 3.0 6 3.6
Triglycerides (mg/dl)
mean ± SD 256.1±58.9 232.2±59.7 276.0±55.3
Atherosclerosis risk group 16 9.6 7 4.2 9 5.4
Table 2.  Number and percentage (%) of subjects aged 13–15 years with increased values of biochemical parameters in venous blood and the mean 
values of biochemical parameters (mean ± SD)
# only subjects with increased values of biochemical parameters in capillary blood were tested.
Specification
Subjects
N=167 (100%)
Risk group subjects
N1=16 (9.6%)
Non-risk group subjects
N2=151 (90.4%)
Physical activity (MVPA points)
mean ± SD 3.6±0.9 4.0±1.1
Table 3. Physical activity of subjects (mean ± SD)
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was 79.8±9.8 mmHg in risk group subjects and 76.3±8.1 
mmHg in non-risk group subjects.
dIscussIon
Numerous clinical studies indicate that atherosclerotic con-
ditions can be found in humans even in early life stages, 
whereas atherosclerosis risk factors significantly influen-
ce the spread and advancement of the problem [30,53].
Our research proved that atherosclerosis risk factors are pre-
sent in young age in humans. Among the 167 tested sub-
jects aged 13–15 years there were found 16 students (9.6%) 
whose lipid level in venous blood proved to be increased, 
where 5 subjects (3%) had increased level of cholesterol 
and 11 subjects (6.6%) had increased level of triglycerides.
The autopsy research conducted in years 1987–1994 by the 
Pathobiological Determinants of Atherosclerosis in Youth 
Research Group (PDAY) covered 2876 subjects aged 15–34 
years and proved the presence of fatty streaks in each te-
sted subject. Moreover, the significant development of fat-
ty streaks in subjects aged 30–34 years has been proved. 
Also there has been proved a positive correlation between 
lipid profile disorders, high BMI, hypertension and pro-
gression of atherosclerotic plaques [31].
Defining levels of total cholesterol, LDL, HDL and tri-
glycerides in blood serum has become a basic clinical test 
in estimation of lipid profile disorders [9,10,22,34,40,43]. 
Epidemiological tests have definitely proved direct depen-
dence between cholesterol level in blood and development 
of atherosclerotic plaque [7,47]. The risk of developing athe-
rosclerosis is close to zero in cases when the cholesterol le-
vel does not exceed 170 mg/dl, but the risk increases with 
the increase of cholesterol level [1]. In the present research 
the average cholesterol value was 242.6±25.4 mg/dl. Such 
condition could lead to development of ischemic heart di-
sease in the future if precautions aimed at reducing chole-
sterol level are not taken. It must, though, be clearly men-
tioned that atherosclerosis could be developed even when 
cholesterol level in blood is low due to the fact that such 
factors as increased blood level of homocysteine, blood co-
agulation disorders and intensification of lipid peroxidation 
processes are widely known to increase atherosclerosis risk 
[13]. Not long ago scientists used to believe that 10% incre-
ase of total cholesterol level increases atherosclerosis risk 
by 20%. Nowadays it has been proved that 10% increase of 
total cholesterol level has much greater influence on athero-
sclerosis risk and increases atherosclerosis risk more than 
40%. Population studies have proved that 1% reduction of 
total cholesterol level in blood serum decreases the risk of 
developing ischemic heart disease by about 2% [1,45]. The 
level of total cholesterol in blood serum could be reduced 
Specification
Subjects
N=167 (100%)
Risk group subjects
N1=16 (9.6%)
Non-risk group subjects
N2=151 (90.4%)
Number of 20 m sections covered
mean ± SD
VO2max (ml/kg/min)
mean ± SD
38.6±10.8
29.3±3.6
40.3±12.7
30.0±4.3
Table 4. Maximal oxygen consumption (VO2max) of subjects (mean ± SD)
Specification
Subjects
N=167 (100%)
Both risk group subjects 
and non-risk group subjects
N=167 (100%)
Risk group subjects
N1=16 (9.6%)
Non-risk group subjects
N2=151 (90.4%)
n % n % N %
HTN 35 20.9 4 25.0 31 20.5
PHTN  30 18.0 2 12.5 28 18.5
Normal blood pressure 102 61.1 10 62.5 92 60.9
Blood pressure
- systolic
mean ± SD
- diastolic
mean ± SD
128.4 ± 13.7
77.0 ± 8.5
135.1 ± 17.1
79.8 ± 9.8
127.0 ± 12.6
76.3 ± 8.1
Table 5.   Number and percentage of subjects with hypertension (HTN), prehypertension (PHTN), normal blood pressure values and mean values of 
arterial blood pressure (mean ± SD)
HTN – hypertension; PHTN – prehypertension.
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       -               -               -               -               -       either by proper diet alone or proper diet combined with in-
tensified physical activity, which significantly reduces the 
risk of heart attack and death caused by ischemic heart di-
sease [25]. The level of total cholesterol in blood serum is 
considered to be normal below 5.2 mmol/l (200 mg/dl), be-
cause the risk of developing ischemic heart disease when 
the level of total cholesterol in blood serum is below 5.2 
mmol/l (200 mg/dl) is insignificant. Cholesterol level within 
the range of 5.2–6.5 mmol (200–250 mg/dl) is considered 
to be pre-hypercholesterolemic, whereas cholesterol level 
which exceeds 6.5 mmol/l is considered to be dangerously 
hypercholesterolemic [41]. It has been proved that the in-
crease of LDL in blood leads to accumulation of choleste-
rol in blood vessel walls and development of atherosclero-
sis [7,47]. Among the subjects tested the authors found two 
students, who belonged to the risk group, with increased va-
lues of LDL; the average value of LDL was 160.6±2.6 mg/
dl. It is widely considered that increased LDL cholesterol 
level is less dangerous for developing atherosclerosis than 
increased total cholesterol level, but LDL level should not 
exceed 135 mg/dl when other atherosclerosis risk factors 
are present (hypertension, obesity). However, LDL chole-
sterol level could be tolerated up to 160 mg/dl when there 
are no additional atherosclerosis risk factors [41].
High level of triglycerides is often connected with low HDL 
level, high LDL level and blood coagulation disorders. A 
triglyceride level which exceeds 150 mg/dl is considered to 
be abnormal, but the triglyceride level limit is considered 
to be 200 mg/dl. In tested subjects the level of triglyceri-
des was found to be abnormal, with a value of 256.1±58.9 
mg/dl. HDL cholesterol level is widely credited with pre-
venting atherosclerosis development. Gordon et al. [19] 
showed, based on the research conducted in Framingham, 
that mortality was four times more frequent in subjects 
with a HDL level of 35 mg/dl and lower compared to sub-
jects with a HDL level equal to or higher than 55 mg/dl. 
One mg/dl increase of HDL level (e.g. by means of regu-
lar physical activity) reduces the risk of developing ische-
mic heart disease within the range of 2–3% [39,49]. Only 
one subject from the risk group proved to have a HDL le-
vel less than 35 mg/dl in the present research (33.1 mg/dl).
It has been proved by clinical research that low level of 
physical activity is one of the most important causes of 
developing cardiovascular diseases [12,46]. This was also 
confirmed by the present research, since subjects in the athe-
rosclerosis risk group were characterized by lower level of 
physical activity (low number of MVPA points) and lower 
level of physical efficiency (low level of maximal oxygen 
consumption), when compared to subjects with a normal 
lipid profile. The reason is the positive metabolic changes 
during physical activities, which reduce the risk of cardio-
vascular diseases. The consequent changes in lipid profile 
are the most beneficial for reduction of triglycerides and 
LDL level as well as increasing HDL level. Also, physical 
activity positively influences insulin sensitivity of tissues 
and reduces insulin resistance. Physical activity along with 
body mass reduction positively influences functioning of 
tunica media in blood vessels, which reduces the risk of 
developing atherosclerosis [35,49].
Hypertension has been widely proved to be among the pri-
mary causes of circulatory system conditions. Hypertension 
induces atherosclerotic changes, widening their range and 
increasing lipid level, which, in turn, causes development 
of atherosclerotic plaques [51]. Epidemiologic tests cle-
arly prove that primary hypertension has been constan-
tly rising in children and youth. Around 20% of youth are 
reported to have prehypertension or hypertension. The ma-
jority of children who are diagnosed with prehypertension 
in the period of 2–3 years develop primary hypertension. 
Hypertension tests are usually followed by interview to de-
fine any predispositions for hypertension or other cardio-
vascular conditions. In the present research 20% of sub-
jects have been diagnosed with hypertension, and subjects 
in the atherosclerosis risk group have been significantly 
more frequently diagnosed with hypertension than sub-
jects with normal lipid profile. Moreover, average blood 
pressure values (both systolic and diastolic) were higher 
in risk group subjects (systolic 135.1±17.1 mmHg; dia-
stolic 79.8±9.8 mmHg) when compared to subjects with 
normal lipid profile (systolic 127.0±12.6 mmHg; diastolic 
76.3±8.1 mmHg). Children and youth with primary hyper-
tension are often diagnosed with low level of HDL chole-
sterol, increased level of triglycerides, abnormal glucose 
tolerance and insulin resistance [8,55].
The research results clearly suggest the necessity of re-
gular lipid level tests in children and youth. Screening te-
sts could be limited to defining levels of total cholesterol 
and triglycerides.
Inferences
1.   9.6% of subjects within the tested population of 167 stu-
dents aged 13–15 years have been diagnosed with incre-
ased biochemical blood parameters.
2.   Hypertension results analysis based on centile charts sho-
wed that subjects with increased lipid profile have been 
significantly more frequently diagnosed with hyperten-
sion compared to subjects with normal lipid profile.
3.   Subjects in the atherosclerosis risk group have been dia-
gnosed with lower levels of physical activity and physi-
cal efficiency.
4.   Students diagnosed with atherosclerosis risk factors re-
quire observation and early prophylactics by adopting 
habits of healthy physical activity. Moreover, such stu-
dents should have blood pressure and lipid profile tests 
performed on a regular basis.
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